"Our results suggest that a 10-day course of moxifloxacin 400 mg daily could be used as a first-line regimen to treat MG infections in settings where assessment of resistance-associated mutations is ...

According to a post hoc analysis of patients with juvenile idiopathic arthritis on tofacitinib, younger patients have higher height velocities than expected, and older patients have normal velocities.

Three more digoxin trials, yet another GLP-1 drug on the horizon, vagal nerve stimulation, trial inside baseball, and more on lipid guidelines are the topics John Mandrola, MD, discusses in this ...

Patients in the province will be able to seek care at pharmacies for conditions like head lice, nasal congestion, dry eye, and ringworm.

As more PAs consider retirement, some areas of the country may face shortages, resulting in worse access to healthcare.

More than one third of US adults in the 2024 National Health Interview Survey report experiencing at least one sunburn.

A vaccinated woman in her fifties rapidly improved on ensitrelvir but had symptomatic and virologic rebound 1 day after completing therapy — quantitative antigen rose markedly from ~145 pg/mL at ...

Those are some of the questions dermatologists face when a patient on systemic therapy for psoriasis does not respond fully, when the patient reacts favorably at first but then treatment effectiveness ...

For years, treatment for metastatic pancreatic cancer has relied on highly toxic chemotherapy regimens that offer survival gains typically measured in months. Most patients diagnosed with advanced ...

Patients with rheumatoid arthritis (RA) and preserved kidney function who started reduced doses of JAK inhibitors had treatment persistence and disease control that were similar to those in patients ...

Denver — Thanks to treatments approved by the FDA in recent years, pediatric dermatologists’ strategy for epidermolysis bullosa (EB) has shifted from providing supportive care to correcting underlying ...

TORONTO — Currently available drugs to treat patients with axial spondyloarthritis (axSpA) are generally effective for symptom control, and many also for structural protection, but not everyone ...